Literature DB >> 17202460

p53 and tumor suppression.

Terry Van Dyke1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17202460     DOI： 10.1056/NEJMcibr066301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD.

Authors:  Amrita Cheema; Chad D Knights; Mahadev Rao; Jason Catania; Ricardo Perez; Brigitte Simons; Sivanesan Dakshanamurthy; Vamsi K Kolukula; Maddalena Tilli; Priscilla A Furth; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 2.  SGK1 survival through various lives may save us all.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2007-07       Impact factor: 4.599

3.  Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan.

Authors:  Yone-Han Mah; Ching-Sheng Hsu; Chen-Hua Liu; Chun-Jen Liu; Ming-Yang Lai; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2011-02-06       Impact factor: 6.047

4.  The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G₁ arrest.

Authors:  Richard L Bennett; Yu Pan; Jaime Christian; Teng Hui; W Stratford May
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

Review 5.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

6.  Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.

Authors:  Jingjing Liu; Qixin Mao; Yan Liu; Xiaomeng Hao; Sheng Zhang; Jin Zhang
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

7.  L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells.

Authors:  E Ayroldi; M G Petrillo; A Bastianelli; M C Marchetti; S Ronchetti; G Nocentini; L Ricciotti; L Cannarile; C Riccardi
Journal:  Cell Death Differ       Date:  2014-08-29       Impact factor: 15.828

8.  Acute and long-term effects of hyperthermia in B16-F10 melanoma cells.

Authors:  Mónica Pereira Garcia; José Roberto Tinoco Cavalheiro; Maria Helena Fernandes
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

9.  Molecular driver alterations and their clinical relevance in cancer of unknown primary site.

Authors:  Harald Löffler; Nicole Pfarr; Mark Kriegsmann; Volker Endris; Thomas Hielscher; Philipp Lohneis; Gunnar Folprecht; Albrecht Stenzinger; Manfred Dietel; Wilko Weichert; Alwin Krämer
Journal:  Oncotarget       Date:  2016-07-12

10.  Association of C-myc and p53 Gene Expression and Polymorphisms with Hepatitis C (HCV) Chronic Infection, Cirrhosis and Hepatocellular Carcinoma (HCC) Stages inzzm321990Egypt

Authors:  Fayed Koutb; Salah Abdel-Rahman; Ehab Hassona; Amany Haggag
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.